Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Focusing on quality patient care in the new global subsidy for malaria medicines.

Moon S, PĂ©rez Casas C, Kindermans JM, de Smet M, von Schoen-Angerer T.

PLoS Med. 2009 Jul 21;6(7):e1000106. doi: 10.1371/journal.pmed.1000106. Epub 2009 Jul 21.

2.

Why the world needs another malaria initiative.

[No authors listed]

Lancet. 2004 Jul 31-Aug 6;364(9432):389-90. No abstract available.

PMID:
15288715
3.

Universal access to malaria medicines: innovation in financing and delivery.

Adeyi O, Atun R.

Lancet. 2010 Nov 27;376(9755):1869-71. doi: 10.1016/S0140-6736(10)61189-0. No abstract available.

PMID:
20940074
4.

Qinghaosu (artemisinin): the price of success.

White NJ.

Science. 2008 Apr 18;320(5874):330-4. doi: 10.1126/science.1155165. Review.

PMID:
18420924
5.

Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?

Laxminarayan R, Over M, Smith DL.

Health Aff (Millwood). 2006 Mar-Apr;25(2):325-36.

6.

Implementation of the Affordable Medicines for Malaria Facility (AMFm) in Ghana: processes, challenges and achievements.

Malm KL, Segbaya S, Forson I, Gakpey KD, Sampong LB, Adjei EA, Bart-Plange C.

J Public Health Policy. 2013 May;34(2):302-14. doi: 10.1057/jphp.2013.12. Epub 2013 Apr 11.

PMID:
23575513
7.

The Affordable Medicines Facility-malaria--a success in peril.

Talisuna AO, Adibaku S, Amojah CN, Amofah GK, Aubyn V, Dodoo A, Juma E, Jackou DH, Mkude S, Okui AP, Ramarosandratana B, Shija SJ.

Malar J. 2012 Nov 8;11:370. doi: 10.1186/1475-2875-11-370.

8.

Making antimalarial agents available in Africa.

Arrow KJ, Gelband H, Jamison DT.

N Engl J Med. 2005 Jul 28;353(4):333-5. Epub 2005 Jul 6. No abstract available.

9.

Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.

Smith N, Obala A, Simiyu C, Menya D, Khwa-Otsyula B, O'Meara WP.

Malar J. 2011 Oct 26;10:316. doi: 10.1186/1475-2875-10-316.

10.

A global subsidy: key to affordable drugs for malaria?

Laxminarayan R, Gelband H.

Health Aff (Millwood). 2009 Jul-Aug;28(4):949-61. doi: 10.1377/hlthaff.28.4.949.

11.

Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.

Yeung S, Patouillard E, Allen H, Socheat D.

Malar J. 2011 Aug 18;10:243. doi: 10.1186/1475-2875-10-243.

12.

Public health. Optimizing investments in malaria treatment and diagnosis.

Cohen JM, Woolsey AM, Sabot OJ, Gething PW, Tatem AJ, Moonen B.

Science. 2012 Nov 2;338(6107):612-4. doi: 10.1126/science.1229045. No abstract available.

PMID:
23118172
13.

The quest for universal access to effective malaria treatment: how can the AMFm contribute?

Matowe L, Adeyi O.

Malar J. 2010 Oct 8;9:274. doi: 10.1186/1475-2875-9-274.

14.

Measuring the AMFm.

Tren R, Hess K.

Lancet. 2011 Mar 5;377(9768):810; author reply 810-1. doi: 10.1016/S0140-6736(11)60302-4. No abstract available.

PMID:
21377565
15.

Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention.

Willey BA, Tougher S, Ye Y; ACTwatchGroup, Mann AG, Thomson R, Kourgueni IA, Amuasi JH, Ren R, Wamukoya M, Rueda ST, Taylor M, Seydou M, Nguah SB, Ndiaye S, Mberu B, Malam O, Kalolella A, Juma E, Johanes B, Festo C, Diap G, Diallo D, Bruxvoort K, Ansong D, Amin A, Adegoke CA, Hanson K, Arnold F, Goodman C.

Malar J. 2014 Feb 4;13:46. doi: 10.1186/1475-2875-13-46.

16.

Malaria plan under scrutiny.

Maxmen A.

Nature. 2012 Oct 4;490(7418):13-4. doi: 10.1038/490013a. No abstract available.

PMID:
23038440
17.

Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.

Yadav P, Cohen JL, Alphs S, Arkedis J, Larson PS, Massaga J, Sabot O.

Malar J. 2012 Aug 28;11:299. doi: 10.1186/1475-2875-11-299.

18.

Innovating for impact: the Affordable Medicines Facility-malaria (AMFm).

Adeyi O, Atun R.

Nat Med. 2009 Sep;15(9):991. doi: 10.1038/nm0909-991b. No abstract available.

PMID:
19734866
19.

Cost of increasing access to artemisinin combination therapy: the Cambodian experience.

Yeung S, Van Damme W, Socheat D, White NJ, Mills A.

Malar J. 2008 May 20;7:84. doi: 10.1186/1475-2875-7-84.

20.

Public health. From financing to fevers: lessons of an antimalarial subsidy program.

Laxminarayan R, Arrow K, Jamison D, Bloom BR.

Science. 2012 Nov 2;338(6107):615-6. doi: 10.1126/science.1231010. No abstract available.

PMID:
23118173
Items per page

Supplemental Content

Write to the Help Desk